Menu

BeyondSPX has rebranded as EveryTicker. We now operate at everyticker.com, reflecting our coverage across nearly all U.S. tickers. BeyondSPX has rebranded as EveryTicker.

Zevia PBC (ZVIA)

$1.12
-0.04 (-3.85%)
Get curated updates for this stock by email. We filter for the most important fundamentals-focused developments and send only the key news to your inbox.

Data provided by IEX. Delayed 15 minutes.

Zevia's Margin Inflection: How a Clean-Label Soda Underdog Is Engineering a Turnaround (NYSE:ZVIA)

Zevia PBC produces zero-sugar, naturally sweetened beverages primarily in the US and Canada, focusing on clean-label sodas with stevia sweetening. It targets health-conscious consumers seeking affordable, mainstream-priced alternatives to traditional and functional sodas, emphasizing sustainability and brand purity.

Executive Summary / Key Takeaways

  • Zevia is executing a credible path to profitability, having achieved its first adjusted EBITDA-positive quarter in Q2 2025 and guiding to near-breakeven for 2026, despite $5 million in incremental tariff headwinds, demonstrating that cost discipline and operational leverage are finally taking hold.

  • The company occupies a defensible niche as the only zero-sugar, clean-label soda priced at mainstream levels, with distribution wins at Walmart (WMT), Albertsons (ACI), and Walgreens (WBA) validating its "affordable better-for-you" positioning against both Big Soda giants and premium functional upstarts.

  • A 48% gross margin and 0.32x EV/Revenue multiple represent a stark discount to beverage peers trading at 2-3x sales, reflecting market skepticism that Zevia can scale profitably—a skepticism that may prove misplaced if 2026 guidance materializes.

  • Two critical variables will determine the thesis: whether Zevia can offset 200 basis points of aluminum tariff pressure through pricing and productivity while maintaining volume growth, and whether its DSD distribution strategy can reduce 75% customer concentration risk.

  • The planned discontinuation of the Tea line in 2026, while trimming 1-1.5 points of top-line growth, will sharpen focus on the 95%-revenue Soda business where innovation (Strawberry Lemon Burst, Orange Creamsicle) is driving the highest velocities in company history.

Setting the Scene: The Zero-Sugar Beverage Battlefield

Zevia PBC, founded in 2007 and launched in 2008, has spent nearly two decades building a beverage business that addresses a singular global health challenge: excess sugar consumption. Unlike the multinational beverage conglomerates that dominate supermarket aisles, Zevia operates as a Public Benefit Corporation, legally obligated to balance shareholder returns with public health outcomes. This structure explains both its mission-driven product design and the inherent tension in its capital allocation decisions, which sometimes prioritize brand purity over near-term profitability.

The company generates revenue through a single operating segment: zero-sugar, naturally sweetened beverages sold primarily in the United States and Canada. By the end of 2025, Zevia had sold over 2.6 billion cans, a cumulative figure that represents a validated consumer demand for stevia-sweetened alternatives that contain no artificial sweeteners, no erythritol , and no artificial colors. Every can is Non-GMO Project verified, gluten-free, Kosher, and vegan, certifications that unlock premium natural retail channels but also constrain ingredient sourcing and production flexibility.

Zevia sits at the intersection of two powerful industry trends. First, the secular shift toward healthier beverages has created a better-for-you soda category growing at mid-single digits while traditional soda declines. Second, consumer backlash against artificial ingredients has opened a clean-label subsegment where Zevia competes with functional brands like Olipop and Poppi, the latter recently acquired by PepsiCo (PEP). The critical distinction: Zevia prices like a mainstream soda ($4-5 per 12-pack) while functional competitors command $8-10, positioning Zevia as the "affordable clean label" option. This pricing strategy is significant because it determines both addressable market size and margin potential in a category where 75% of net sales flow through just ten customers.

Technology, Products, and Strategic Differentiation

Zevia's core differentiation is not software or hardware but its proprietary formulation and stevia-sweetening process that delivers a "more sugar-like taste experience" without artificial additives. This is important because taste has been the primary barrier to diet soda adoption for decades; if Zevia can consistently close the gap while maintaining clean-label credentials, it creates a switching cost for health-conscious consumers who have tried and rejected aspartame-based alternatives. The 2025 innovation pipeline delivered proof: Strawberry Lemon Burst and Orange Creamsicle became the most successful launches in company history, with Peaches & Cream ranking as the fastest-selling new item ever on Amazon (AMZN) and Strawberries & Cream immediately becoming a top-3 velocity driver at Kroger (KR).

The packaging refresh rolling out in early 2026 amplifies this differentiation. By prominently featuring "Soda Made Better" messaging and emphasizing zero sugar, no artificial colors, and no artificial sweeteners, Zevia is repositioning itself from a niche diet brand to a mainstream soda alternative. Proprietary research showing a meaningful increase in purchase intent with the new design suggests the company can drive conversion without increasing promotional spending, a critical lever for expanding gross margins from the current 48% toward the high-40% range management targets for 2026.

Zevia's B Corp status and sustainability credentials—exclusively using aluminum cans since 2007, avoiding over 34,000 metric tons of plastic—create a moat in natural channels but also impose cost structures that competitors avoid. As aluminum tariffs rise to 50%, Zevia cannot simply shift to plastic to mitigate costs, making its supply chain diversification strategy and stevia sourcing from three qualified suppliers essential to maintaining margin stability. The decision to discontinue the Tea line in 2026, while costing 1-1.5 points of growth, will eliminate a lower-margin distraction and concentrate resources on the carbonated platform where innovation is resonating most strongly.

Financial Performance & Segment Dynamics: Evidence of a Turnaround

The 2025 financial results serve as compelling evidence that Zevia's Productivity Initiative is fundamentally realigning the cost structure to support profitable growth. Net sales grew 4% to $161.3 million, a modest pace that masks more important underlying improvements. Gross margin expanded 160 basis points to 48%, driven by better product costing and inventory management rather than price increases. This demonstrates operational leverage: the company is making more money per can sold while investing in distribution expansion and marketing.

Loading interactive chart...

The adjusted EBITDA loss improved dramatically from $15.2 million in 2024 to $4.7 million in 2025, with Q2 marking the first profitable quarter as a public company at $0.2 million and Q4 achieving breakeven at approximately $50,000. This progression shows the $20 million annualized savings target is achievable, with $15 million already realized and the final $5 million expected by end of Q2 2026. The savings are being reinvested into brand building and innovation, creating a self-funding growth engine that reduces reliance on external capital.

Loading interactive chart...

Quarterly cadence reveals strategic trade-offs. Q1 2025 gross margin hit 50.1% despite a 2% sales decline, showing the immediate payoff from cost actions. Q2's 10.1% sales growth came with 680 basis points of gross margin expansion to 48.7%, though promotional activity increased. Q3's 12% sales growth exceeded expectations but gross margin fell 350 basis points to 45.6% due to $0.8 million in inventory obsolescence from the packaging refresh and full aluminum tariff realization. Q4's 4% sales decline reflected lapping the Walmart pipeline fill, yet adjusted EBITDA reached breakeven ahead of expectations. This pattern demonstrates management's willingness to prioritize margin health, a discipline that will be tested in 2026 as tariffs intensify.

Loading interactive chart...

The balance sheet provides a modest but sufficient cushion. With $25.4 million in cash and an undrawn $20 million revolver, Zevia has adequate liquidity for operations beyond the next 12 months. The minimal debt-to-equity ratio of 0.02 gives management flexibility to weather tariff headwinds without covenant pressure, though the $58.9 million Tax Receivable Agreement liability through 2040 represents a future cash drag that will only materialize if the company generates sufficient taxable income.

Competitive Context: A Squeezed but Defensible Position

Zevia's competitive positioning is best understood through the lens of pricing and distribution rather than market share, which remains below 1% of carbonated beverages. Against multinational giants Coca-Cola (KO), PepsiCo, and Keurig Dr Pepper (KDP), Zevia's 48% gross margin compares favorably to their 54-55% levels, despite operating at one-hundredth the scale. This proves the premium clean-label positioning commands pricing power. The risk is that these giants can use their scale to rapidly respond—PepsiCo's Poppi acquisition and Coca-Cola's Simply Pop launch demonstrate they are entering the better-for-you space, potentially using shelf space leverage to squeeze Zevia's distribution gains.

Against functional soda upstarts Olipop and Poppi, Zevia's key advantage is affordability. As CEO Amy Taylor noted, Zevia is significantly more competitively priced while offering a great tasting and clean label option. In a tightening consumer spending environment, a $4-5 twelve-pack has a much larger addressable market than an $8-10 functional beverage. The "modern soda set" at Walmart, where Zevia is an anchor brand, validates that mainstream retailers see value in offering a clean-label option at mainstream prices.

Celsius Holdings (CELH) presents a different competitive threat. With $2.5 billion in revenue and 14% operating margins, Celsius dominates the functional energy segment where Zevia's energy drink line remains a small, natural-channel focused afterthought. This shows where Zevia is choosing not to compete; management explicitly states the focus is on soda while energy remains an opportunity for future development. The comparison highlights Zevia's strategic discipline—rather than dilute resources chasing Celsius in energy, it is consolidating its soda leadership.

National Beverage Corp (FIZZ), the maker of LaCroix, offers the most direct parallel with its 37% gross margins and 19% operating margins. Zevia's 11-point gross margin advantage reflects the value of flavored soda versus unflavored sparkling water, but FIZZ's superior operating margins reveal the efficiency gap Zevia must close. FIZZ achieves this with zero debt and ruthless cost control, a model Zevia is emulating through its Productivity Initiative.

Outlook, Management Guidance, and Execution Risk

Management's 2026 guidance frames a pivotal year where Zevia must prove it can grow profitably despite external headwinds. The net sales range of $169-173 million implies 6% growth at the midpoint, but this includes a 1-1.5 point drag from discontinuing Tea. On an apples-to-apples basis, core soda growth is targeted at 7-8%, a modest acceleration that suggests management is prioritizing profitable volume over aggressive expansion. The adjusted EBITDA guidance of -$1 million to +$0.5 million incorporates $5 million of incremental tariff costs, meaning operational improvements must generate $10-11 million of EBITDA just to offset tariffs and reach breakeven.

The quarterly cadence shift is strategically significant. Higher volumes expected in Q1 and Q3—versus the traditional Q2/Q3 seasonality—reflect the national Costco (COST) program launching in January 2026. Costco yields lower gross margins but serves as a massive trial and awareness driver, essentially functioning as a marketing investment that hits the P&L through margin dilution rather than SG&A. The Q2 headwinds from lapping Walgreens and Albertsons sell-ins, combined with marketing spend shifting to Q3 to align with the new packaging rollout, create a temporary trough that management must navigate.

Gross margin assumptions in the "high 40% range" starting Q2 2026 are ambitious given the 200 basis point tariff headwind. Management plans to mitigate this through price increases with elasticity assumptions of 1.1, product portfolio adaptations, and continued productivity savings. This tests whether Zevia's clean-label differentiation is strong enough to support pricing power. Failure to pass through costs would compress margins back toward the 45% range seen in Q3 2025, derailing the profitability thesis.

The final $5 million tranche of Productivity Initiative savings arriving in late Q2 2026 provides a tailwind, but only if the company can maintain growth while harvesting these efficiencies. Management's bias toward reinvesting savings into brand building and innovation is strategically sound but creates execution risk—if the marketing ROI doesn't materialize, Zevia will have sacrificed margin for no competitive gain.

Risks and Asymmetries: What Could Break the Thesis

The most material risk is customer concentration. With the top customer representing 14% of sales and the top ten accounting for 75%, Zevia's distribution gains are simultaneously its greatest strength and vulnerability. A decision by Walmart to reduce shelf space or delist Zevia in favor of private label or a better-funded competitor could instantly erase 15-20% of revenue. This amplifies the power of multinationals like PepsiCo and Coca-Cola, who can bundle Zevia-style offerings into broader category management deals.

Aluminum tariffs represent a quantifiable margin threat. The 50% tariff rate creates a $5 million incremental cost in 2026, equivalent to 3% of net sales. Management's plan to offset this through pricing, sourcing changes, and productivity requires flawless execution across multiple fronts. If tariff relief doesn't materialize by Q3, or if competitors absorb costs to gain share, Zevia could face the unpalatable choice of margin compression or volume loss.

The competitive landscape is bifurcating in ways that could squeeze Zevia from both ends. Big Soda's entry into better-for-you brings massive marketing budgets and shelf space leverage, while functional upstarts like Olipop continue educating consumers on gut health benefits that Zevia doesn't offer. Zevia's middle positioning—clean label but not functional, affordable but not cheap—could become a no-man's land if consumers polarize toward either value or premium functionality.

Supply chain dependencies on stevia extract from three qualified suppliers and aluminum cans from a concentrated base create vulnerability to cost inflation and availability shocks. While diversification efforts are underway, any disruption could force Zevia to reformulate or miss production targets, damaging retailer relationships in a business where on-shelf availability directly drives velocity.

Finally, the B Corp status legally requires the board to balance stakeholder interests against shareholder value. This could prevent management from taking aggressive profit-maximizing actions—such as switching to plastic packaging to avoid tariffs or cutting marketing spend to hit short-term earnings targets—creating a potential misalignment with public market expectations.

Valuation Context: Pricing in Distress, Not Turnaround

At $1.13 per share, Zevia trades at an enterprise value of $51.5 million, representing 0.32 times trailing revenue of $161.3 million. This multiple stands at a 70-85% discount to beverage peers: Celsius trades at 3.6x, National Beverage at 2.4x, Keurig Dr Pepper at 3.2x, and PepsiCo at 2.7x. Even adjusting for Zevia's smaller scale and net losses, the valuation gap reflects market skepticism that the company can achieve sustainable profitability, a view that 2025's breakeven Q4 and 2026's guidance directly challenge.

The company's balance sheet provides both support and constraint. With $25.4 million in cash and minimal debt, Zevia has a 15-month runway at current burn rates, but the -$5 million free cash flow in 2025 shows capital efficiency remains elusive. The 2.08 current ratio and 1.30 quick ratio indicate adequate liquidity, but the -28.43% return on equity and -9.14% return on assets demonstrate that every dollar invested is currently destroying value. This quantifies the urgency of the profitability turnaround; if 2026 guidance is missed, the market will likely price in a going-concern discount rather than a growth premium.

For an unprofitable company, revenue multiples and cash position matter more than earnings-based metrics. Zevia's 0.47 price-to-sales ratio compares to 2.6-3.5x for profitable peers, suggesting that if management can deliver on the 2026 breakeven target, multiple expansion could provide significant upside. The key valuation driver is the trajectory toward positive free cash flow, which would transform Zevia from a turnaround speculation into a viable small-cap growth story.

Conclusion: A Credible Turnaround at an Unforgiving Price

Zevia's investment thesis hinges on whether a subscale beverage company can engineer a profitability inflection while competing against multinational giants and well-funded upstarts. The 2025 results provide compelling evidence that the answer is yes. The Productivity Initiative's $20 million in savings, gross margin expansion to 48%, and the first adjusted EBITDA-positive quarter demonstrate operational leverage. Distribution wins at Walmart, Albertsons, and Walgreens validate that the "affordable clean label" positioning resonates with mainstream retailers.

The central tension is valuation versus execution. At 0.32x EV/Revenue, the market prices Zevia as a distressed asset, yet management guides to breakeven EBITDA in 2026 even while absorbing $5 million in tariff costs. This asymmetry creates a favorable risk/reward if execution holds, but leaves no margin for error. The two variables that will decide the outcome are tariff mitigation—whether pricing power and sourcing changes can offset 200 basis points of cost pressure—and distribution diversification.

The discontinuation of Tea and the focus on soda innovation show strategic discipline, while the Jelly Roll marketing campaign's 2.4 billion impressions prove the brand can break through culturally. However, the B Corp status and clean-label constraints limit management's flexibility in ways that traditional beverage companies don't face. For investors willing to accept the execution risk, Zevia offers a rare combination: a credible path to profitability, a defensible market niche, and a valuation that prices in failure rather than success. The question is whether the turnaround can happen fast enough to outrun the industry's competitive and cost pressures.

Create a free account to continue reading

Get unlimited access to research reports on 5,000+ stocks.

FREE FOREVER — No credit card. No obligation.

Continue with Google Continue with Microsoft
— OR —
Unlimited access to all research
20+ years of financial data on all stocks
Follow stocks for curated alerts
No spam, no payment, no surprises

Already have an account? Log in.